Franca B. Barton - Concepedia

Author

Franca B. Barton

Maryland Medical Research Institute ORCID

Also Known As

" Thomas, F Barton, F. B. Barton, F. Barton, F.B. Barton, FRANCA B. BARTON, Franca B Barton, Franca B. Barton, Franca Barton, Franca Benedicty Barton

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Maryland Medical Research Institute Emmes (United States)University of Miami University of Minnesota National Institutes of Health

About

Franca B. Barton is an author at Maryland Medical Research Institute specializing in medicine, diabetes, and islet transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.4K
2	Engineering	3	3	218
3	Health Sciences	3	3	420
4	Education	2	2	105
5	Public Health	1	1	94

Franca B. Barton

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia Samuel Charache, Michael L. Terrin, Richard D. Moore, New England Journal of Medicine	1995	2.3K
International Trial of the Edmonton Protocol for Islet Transplantation A. M. James Shapiro, Camillo Ricordi, Bernhard J. Hering, New England Journal of Medicine	2006	1.9K
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia Martin H. Steinberg, Franca B. Barton, Oswaldo Castro, JAMA	2003	889
Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010 Franca B. Barton, Michael R. Rickels, Rodolfo Alejandro, Diabetes Care	2012	717
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Matthew D. Davis, M Fisher, Ronald E. Gangnon, PubMed	1998	460
Fetal Hemoglobin in Sickle Cell Anemia: Determinants of Response to Hydroxyurea Martin H. Steinberg, Zhi-Hong Lu, Franca B. Barton, Blood	1997	396
Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes Melena D. Bellin, Franca B. Barton, Andrew Heitman, American Journal of Transplantation Inexorable DeclineImmunodeficienciesImmunologyTransplantation MedicinePancreas Transplantation	2012	348
Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent Samuel Charache, Franca B. Barton, Richard D. Moore, Medicine	1996	331
Design of the multicenter study of hydroxyurea in sickle cell anemia Samuel Charache, Michael L. Terrin, Richard D. Moore, Controlled Clinical Trials Drug SafetyTherapeutic Drug MonitoringTranslational MedicinePainful CrisesBiochemistry	1995	274
A pilot randomized trial comparing symptomatic vs. hemoglobin‐level‐ driven red blood cell transfusions following hip fracture Jeffrey L. Carson, Michael L. Terrin, Franca B. Barton, Transfusion	1998	236

Page 1